Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients

O. V. Lovacheva, N. V. Chernichenko, L. N. Lepekha, V. V. Erokhin, O. A. Rosenberg (Moscow, Russia)

Source: Annual Congress 2003 - Management of tuberculosis
Session: Management of tuberculosis
Session type: Thematic Poster Session
Number: 3250
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. V. Lovacheva, N. V. Chernichenko, L. N. Lepekha, V. V. Erokhin, O. A. Rosenberg (Moscow, Russia). Use of surfactant-BL (S-BL) in complex treatment of pulmonary TB patients. Eur Respir J 2003; 22: Suppl. 45, 3250

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The efficacy of treatment with surfactant-BL (S-BL) in patients with destructive pulmonary tuberculosis
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Treatment patients with pulmonary tuberculosis (PT) and accompanying pathologies by DOTS strategy
Source: Eur Respir J 2005; 26: Suppl. 49, 192s
Year: 2005

The experience of use plasmaferesis in complex treatment in patients with pulmonary sarcoidosis (PS)
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

Monitoring of new pulmonary TB patients: detection and treatment
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009


Features of intravenous anti TB therapy in patients with first diagnosed pulmonary TB in the intensive phase of treatment
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017

Intensive tobacco smoking as a factor of the decrease of treatment effectiveness in patients with pulmonary tuberculosis (TB)
Source: Eur Respir J 2005; 26: Suppl. 49, 157s
Year: 2005

Diagnosis and treatment delay in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 520s
Year: 2003

Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with BA
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014

Influence of modern basic therapy of bronchial asthma (BA) on the course of pulmonary TB in patients with pulmonary TB associated with asthma
Source: International Congress 2016 – Tuberculosis: immune responses of CD8+ T cells, value of interferon-gamma and other cytokines, Th2 responses, BCG, and biomarkers
Year: 2016

Effects of complex treatment with izofon of a pulmonary tuberculosis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 652s
Year: 2004

Treatment results in patients with drug resistant pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 612s
Year: 2002

Application of psychotherapy in medical treatment of patients with first revealed pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 504s
Year: 2006

Safety aspects of endobronchial valve application in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Influence of intravenous laser blood irradiation on preoperative care of pulmonary TB patients
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016

Pitfalls in the registration and delay in the treatment of patients with culture positive pulmonary tuberculosis (CPPTB)
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007


Almost half the patients treated for pulmonary tuberculosis (TB) show evidence of obstructive airways disease (OAD)
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


Results of surfactant-BL (C-BL) implementation in a complex pulmonary MDR-TB chemotherapy
Source: Eur Respir J 2006; 28: Suppl. 50, 860s
Year: 2006

A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Study of states of leukocytes in blood of pulmonary tuberculosis patients with different efficacy of treatment.
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020